Lykke Hinsch Gylvin: What makes a Medical / Science Congress visit truly energizing

Lykke Hinsch Gylvin posted on LinkedIn:

“This is what makes a Medical / Science Congress visit truly energizing – the opportunity to engage with and listen to people who experience our innovation. As we in Boehringer Ingelheim presented positive results from our Beamion LUNG-1 trial at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, I had this unique chance to understand from Loriana Hernández-Aldama, a 2x cancer survivor and patient advocate, her observations on diversity in clinical trials, at the conference venue.

Given her experiences, she is now an ardent supporter of enhanced patient voice in drug development. To be acknowledged by her that we are on the right path to engaging with patients early on in development and trial design is a true commendation to the Boehringer team’s commitment to patient-powered progress. Please see below excerpts of our discussion.

Loriana, thank you for all your work! I look forward to us continuing this dialogue.”

Video attached to the post.
Source: Lykke Hinsch Gylvin/LinkedIn

Lykke Hinsch Gylvin, MD EMBA, is the Chief Medical Officer and Head of Global Medicine at Boehringer Ingelheim. She has experience in drug development, from early stages through post-approval, and expertise in Global Medical Affairs across immunology, respiratory, ophthalmology, neuroscience, metabolism, and rare diseases.

Loriana Hernández-Aldama, founder of ArmorUp for Life Foundation, is a patient advocate on the Patient Family Advisory Council at Johns Hopkins Hospital and a member of the National Quality Forum’s Patient Engagement Advisory Committee. A two-time cancer survivor and Emmy Award-winning journalist, she is a transformative keynote speaker.